NCT04952597 2024-10-26
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
BeiGene
Phase 2 Completed
BeiGene
Mayo Clinic
Institut Claudius Regaud
Samsung Medical Center
ChineseAMS
Taipei Veterans General Hospital, Taiwan
Eli Lilly and Company